EUCTR2009-013029-41-IT进行中（未招募）不适用
Proteomic profile analysis to classify advanced pancreatic adenocarcinoma patients for clinical outcome after treatment with PDXG (cisplatin, docetaxel, capecitabine, gemcitabine) or PEXG (cisplatin, epirubicin, capecitabine, gemcitabine) regimen. - ND
FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR0 个研究点开始时间: 2009年6月11日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •to include patients with cytological or histological diagnosis of pancreatic adenocarcinoma at stage III or IV who are candidate to receive upfront chemotherapy according to PDXG or PEXG regimen.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •patients withouth cytological or histological diagnosis of pancreatic adenocarcinoma at stage III or IV who are candidate to receive upfront chemotherapy according to PDXG or PEXG regimen.
研究者
相似试验
已完成
不适用
Proteomic analysis for establishing a biomarker panel for the onset of Adult T-cell Leukemia (ATL)JPRN-UMIN000038467niversity of the Ryukyus85
已完成
不适用
Proteomics and pancreatic cystic neoplasms: a pilot studyISRCTN10626053Geneva University Hospital (Switzerland)10
已完成
不适用
Study of proteomics for identification of novel prognostic biomarkers in patients with hepatocellular carcinoma and intrahepatic cholangiocarcinoma undergoing surgical resectioHepatocellular carcinoma and Intrahepatic cholangiocarcinomaHepatocellular carcinoma, Intrahepatic cholangiocarcinoma, Biomarkers, Proteomics, PrognosisTCTR20220113002Ratchadapisek Research Funds115
进行中（未招募）
不适用
Evaluación mediante proteómica de biomarcadores proteicos asociados con el tratamiento con Eplerenona versus espironolactona en pacientes post-infarto agudo de miocardio, diabéticos con hipertensión arterial no controlada y disfunción ventricular sistólica leve”Identification of proteomic biomarkers associated with eplerenone treatment versus spironolactone in post-acute coronary syndrome patients, with non-controlled arterial hypertension and ventricular dysfunction - PROMETEODisfunción ventricular leve-moderada post-infarto agudo de miocardio en pacientes diabéticos con hipertensión arterial no controlada.Low-moderate ventricular dysfunction in post-acute coronary syndrome patients with diabetes and non-controlled arterial hypertension.EUCTR2008-001192-29-ESFundación Investigación y Desarrollo en el Area Cardiovascular
进行中（未招募）
不适用
Análisis proteómico del plasma y plaquetas de pacientes con Diabetes tipo II con enfermedad arterial coronaria estabilizada. Modificación por el tratamiento con clopidogrel. Estudio piloto. - CIDDiabetes Mellitus Tipo II con enfermedad coronaria estabilizadaEUCTR2006-002292-40-ESFundación para la Investigación y Desarrollo en el Área Cardiovascular (FIC)